期刊文献+

人源化抗体构建过程中假链的产生及应对策略 被引量:1

A Simple and Rapid Protocol for Cloning of the Functional V Kappa Chain from Aberrant-chain-positive Murine Hybridomas
下载PDF
导出
摘要 目的在人源化抗体构建过程中,采用方便、快捷的分子克隆手段,消除SP2/0内源性畸形轻链转录本以获得正确的轻链cDNA。方法在mRNA抽提时,不用常规的TRIZOL法抽提总RNA,而采用经腹腔培养,生长状态良好的杂交瘤细胞,用QIAGEN公司Oligotex Direct mRNA Purification Kit,将polyA+的mRNA富集。可有效减少畸变转录本的含量,提高功能型mRNA的丰度。利用polyA+RNA,采用RT-PCR,我们成功地克隆到了轻链可变区序列,序列分析证实读码框完全正确,属于轻链可变区基因。结果NCBI数据库BLAST显示,克隆的基因序列符合小鼠Ig可变区特征,具有正确的CDR和FR功能区及VJ连接区。结论采用polyA+mRNA富集技术,成功克隆获得阻断型抗人CD154 mAb(4F1)单克隆抗体的轻链、重链可变区基因,成功地消除了SP2/0内源性畸形转录本对免疫球蛋白功能性轻链基因的影响。 Objective To eliminate endogenous aberrant kappa chain transcripts from sp2/0-derived hybridoma cells by a simple and rapid cloning strategy. Methods In order to eliminate the unfunctional V kappa transcripts which may hinder or prevent the amplification of correct V kappa chain, Oligotex Direct mRNA Purification system was employed to covalently bind polyA^+ mRNA with higher capacity and accuracy to reduce the endogenous abVk contamination. Results The result of NCBI gene data bank evidenced that the cDNA we got by Oligotex Direct mRNA Purification kit was correct with typical CDRs and FRs domain and functional VJ recombination site. Conclusion This protocol describes the application of a reverse transcriptase PCR strategy to allow the cloning and sequencing of the functional kappa light chain cDNAs from murine hybridomas co-exPressing aberrant endogenous kappa chain mRNAs.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2006年第6期911-914,共4页 Suzhou University Journal of Medical Science
基金 国家高技术研究发展计划(863)资助(No.2001AA215341) 江苏省自然科学基金资助(No.BK2001211)
关键词 畸形转录 假基因 杂交瘤 unfunctional transcripts aberrant chain hybridoma
  • 相关文献

参考文献7

  • 1Duan L, Pomerantz RJ. Elimination of endogenous aberrant kappa chain transcripts from sp2/0 - derived hybridoma cells by specific ribozyme cleavage: utility in genetic therapy of HIV-1 infections[J]. Nucleic Acids Res,1994, 22(24): 5433 - 8.
  • 2Chang X, Cul H, Feng J, et al. Preparation of humanized ovarian carcinoma anti-idiotypic minibody [J].Hybrid Hybridomics, 2003, 22(2):109 - 15.
  • 3Coloma MJ, Hastings A, Letitia A, et al. Novel Vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction[J]. J Immunol Methods, 1992, 152:89-104.
  • 4Yuan X, Gubbins MJ, Berry JD, et al. A simple and rapid protocol for the sequence determination of functional kappa light chain cDNAs from aberrant-chain-positive routine hybridomas[J]. J Immunol Methods, 2004 Nov, 294 (1-2): 199-207, Epub 2004 Oct 4.
  • 5樊一笋,张学光,邱玉华,朱华亭,於葛华.两株抗人CD40配体单克隆抗体的制备及生物学特性的研究[J].中国免疫学杂志,2002,18(6):388-391. 被引量:8
  • 6Martin ACR. Accessing the kabat antibody sequence database by computer [J]. PROTEINS: Structure,Function and Genetics,. 1996, 25: 130-133.
  • 7William I.C, Eileen M, Shoshana L. Hybridoma fusion cell lines contain an aberrant kappa transcript[J]. Mole Immunol, 1988, 10(25): 991-995.

二级参考文献10

  • 1[1]Armitage R J, Faoslow W C, Strokbine L et al. Molecular and biological characterization of a murine ligand for CD40[J]. Nature, 1992;357:80
  • 2[2]Villa A, Notarangelo L D, Di santo et al. Organization of the human CD40L gene: implications for molecular defects in chromosome-linked hyper-lgM syndrome and prenatal diagnosis[J]. Proc Natl Acad Sci USA, 1994;91:2110
  • 3[3]Durie F H, Foy T M foy, Aruffo A et al. The role of CD40 in the regulation of humoral and cell mediated immunity[J]. Immunol Today, 1994;15:406
  • 4[4]Datta S K, Kalled et al. CD40-CD40L interaction in autoimmtme disease [J]. Arthritis Rhcum, 1997 ;40:1735
  • 5[5]Larson C P,Elwood E T et al. Long-term acceptanc of skin and cardiac allgrafts after blocking CD40 and CL28 pathways[ J]. Nature, 1996;381:434
  • 6[6]Zhauhua Zhou, Jiangfang Wang, Xueguang Zhang et al. An angonist antihuman CD40 monoclonal antibody that induces dendritic cell formation and muraturation and inhibits proliferation of a myeloma cell line[ J]. Hybridoma, 1999; 18:471
  • 7[7]Zor T, Selinger. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies[J]. Anal Biochem, 1996;15:236
  • 8[8]Sun H, Subbotin V, Chon C et al. Prevontion of chronic rejection in mouse aortic allografts by combined tretment with CTLA4-1g and antiCD40 ligand monoclonal antibody[J] .Transplantation, 1997;64:1838
  • 9[9]Zheng X X,Schachter A D, Vasconcellosl et al. Incronsed CD40 ligand gene expression during human renal and murine islet allograft rejection [J]. Transplantation, 1998 ;65:1512
  • 10[10]Kirk A D,Burkly L C, Batty D S et al . Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman parimates[J] .Nature Med,1999;5:686

共引文献7

同被引文献13

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部